11 studies found for:    17242396 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: ESHAP-Imatinib
2 Unknown  A Multi-Centre Phase II Study Using Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT
Condition: Metastatic Seminoma
Intervention: Drug: Carboplatin AUC-10
3 Recruiting Nonmyeloablative Haploidentical Transplant Followed by MLN9708
Conditions: Acute Leukemia;   Chronic Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Multiple Myeloma
Intervention: Drug: MLN9708
4 Active, not recruiting Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
Condition: Lymphoma
Interventions: Drug: RCOMP;   Drug: RCHOP
5 Suspended BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM
6 Completed
Has Results
Imexon for Relapsed Follicular and Aggressive Lymphomas
Conditions: Follicular Lymphoma;   Small Lymphocytic Lymphoma;   Marginal Zone Lymphoma;   Lymphoplasmacytic Lymphoma;   Diffuse Large B Cell Lymphoma;   Mantle Cell Lymphoma;   Burkitt's Lymphoma
Intervention: Drug: Imexon
7 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
Conditions: Lymphoma, Follicular;   Stem Cell Transplantation
Intervention: Drug: Reduced_intensity conditioning
8 Active, not recruiting Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide
9 Active, not recruiting
Has Results
Proton Therapy for Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Radiation: Proton Radiation Plan;   Radiation: Conventional Photon Radiation Plan;   Radiation: Intensity Modulated Radiation Plan
10 Completed Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function
Conditions: Neoplasms;   Lymphoma
Interventions: Drug: Pazopanib;   Drug: Pazopanib (GW786034)(GW786034)
11 Unknown  Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Dasatinib

Indicates status has not been verified in more than two years